Trial Profile
Assessment of pulmonary endothelial function in pulmonary artery hypertension with the use of 123I-MIBG scintigraphy
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 19 Feb 2018
Price :
$35
*
At a glance
- Drugs Iobenguane (Primary)
- Indications Pulmonary hypertension
- Focus Pharmacokinetics
- 27 Jan 2018 Status changed from recruiting to active, no longer recruiting, according to the results published in the International Heart Journal
- 27 Jan 2018 Results published in the International Heart Journal
- 23 Sep 2015 New trial record